Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression

By Hall Ben  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 469-479

Springer Publishing Company

Access to resources Recommend Favorite

Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer

By Davies Simon   Watkins Gareth   Mansel Robert   Jiang Wen  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1909-1918

Springer Publishing Company

Access to resources Recommend Favorite

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms

By Wilson-Edell Kathleen   Yevtushenko Mariya   Rothschild Daniel   Rogers Aric   Benz Christopher  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 287-298

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma

By Galoian Karina   Guettouche Toumy   Issac Biju   Qureshi Amir   Temple H.  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2335-2341

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

By            

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1156-1162

Spandidos Publications

Access to resources Recommend Favorite